Research Article
The Clinical Characteristics and Prognostic Nomogram for Head and Neck Cancer Patients with Bone Metastasis
Figure 5
DCA of the prognostic nomogram for the survival prediction of HNC patients with bone metastasis. (a) 12-month survival benefit in the training group. (b) 24-month survival benefit in the training group. (c) 36-month survival benefit in the training group. (d) 12-month survival benefit in the validation group. (e) 24-month survival benefit in the validation group. (f) 36-month survival benefit in the validation group.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |